03.07.2018 • News

Kamal Abbasi Joins Kamedis’ Board of Director

Kamedis, a provider of products for the treatment of chronic skin disorders, announced the addition of Kamal Abbasi to its board of directors. Abbasi formerly served as area vice president of Nestle Skin Health’s Galderma business for Asia Pacific. He is currently vice president at Sinclair Pharma with responsibility for Asia Pacific, Middle East/North Africa and Central/Eastern Europe.

Abbasi, a British citizen, is a medical doctor and obtained his degree from the Sindh Medical University in Karachi, Pakistan. His appointment coincides with a major growth initiative by Kamedis in Central and Eastern Europe.

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Interview

Driving Transformation
Interconnected Global Chemicals Logistics

Driving Transformation

DP World is reshaping global chemical supply chains. Christene Smith of CHEManager interviews Markus Kanis, Global SVP Chemicals, on the company’s roadmap, new technologies, and the evolving demands of global trade.

most read